Drugs toxic to the bone marrow that target the stromal cells

Immunopharmacology

Volumn 46, Issue 2, 2000, Pages 103-112

  Guest, Ian ^a   Uetrecht, Jack ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone marrow stromal cells; Bone marrow toxicity; Drugs

Indexed keywords

ANTINEOPLASTIC AGENT; AUROTHIOMALATE; BENZENE; BUSULFAN; CADMIUM; CARMUSTINE; CEFTAZIDIME; CYCLOPHOSPHAMIDE; DICLOFENAC; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PIPERANOMETOZINE;

AGRANULOCYTOSIS; BONE MARROW CELL; BONE MARROW TOXICITY; CELL PROLIFERATION; DRUG MECHANISM; DRUG SENSITIVITY; EXTRACELLULAR MATRIX; HEMATOPOIETIC CELL; HUMAN; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROMA CELL;

EID: 0033980668     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00168-X     Document Type: Article

References (68)

1. Aaron S., Davis P., Percy J. Neutropenia occurring during the course of chrysotherapy: a review of 25 cases. J. Rheumatol. 12:1985;897-899.
2. Aizawa S., Nakano M., Yaguchi M., Kuriyama Y., Iwase O., Toyama K., Tanaka K., Hoshi H., Sugimoto K., Kaido A., Imai T., Nabeshima R., Handa H. Possible involvement of bone marrow stromal cells in agranulocytosis caused by vesnarinone treatment. Acta Haematol. 98:1997;140-146.
3. Ali-Osman F., Giblin J., Berger M., Murphy M.J., Rosenblum M.L. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas. Cancer Res. 45:1985;4185-4191.
4. Anderson R.W., Matthews K.I., Crouse D.A., Sharp J.G. In vitro evaluation of hematopoiesis in mice treated with busulphan or nitrogen mustard. Biomedecine. 36:1982;149-152.
5. Andrews, L.S., Snyder, R., 1986. Toxic effect of solvents and vapors. In: Klaassen, C.D., Amdur, M.O., Doull, J. (Eds.), Casarett and Doull's Toxicology. The Basic Science of Poison. Macmillan, New York, 1986, pp. 636-668.
6. Bedford P., Eisenbrand G. DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas. Cancer Res. 44:1984;514-518.
7. Breeden J.H., Vollmer J.T., Twomey P.L. Toxicity of very high dose nitrosourea administration. Cancer. 50:1982;1728-1733.
8. Busch F.W., Tillmann A., Becker E.W., Owsianowski M., Berg P.A. The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), on bone marrow progenitor cells and peripheral lymphocytes. Eur. J. Clin. Pharmacol. 42:1992;629-634.
9. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068-2101.
10. Chabannon C., Torok-Storb B. Stem cell-stromal cell interactions. Curr. Top. Microbiol. Immunol. 177:1992;123-136.
11. Ciucci A.G. A review of spontaneously reported adverse drug reactions with diclofenac sodium (Voltarol). Rheumatol. Rehabil. Suppl. 2:1979;116-121.
12. Clark B.R., Keating A. Biology of bone marrow stroma. Ann. N.Y. Acad. Sci. 770:1995;70-78.
13. Cohen G.I., Greenberger J.S., Canellos G.P. Effect of chemotherapy and irradiation on interactions between stromal and hemopoietic cells in vitro. Scanning Electron Microsc. I:1982;359-365.
14. Curry J.L., Trentin J.J., Wolf N. Hemopoietic spleen colony studies: II. Erythropoiesis. J. Exp. Med. 125:1967;703-720.
15. Deryugina E.I., Muller-Sieburg C.E. Stromal cells in long-term cultures: keys to the elucidation of hematopoietic development. Crit. Rev. Immunol. 13:1993;115-150.
16. Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu. Rev. Immunol. 8:1990;111-137.
17. Dunn C.D.R. The chemical and biological properties of busulphan ('Myleran'). Exp. Hematol. 2:1974;101-117.
18. Fibbe W.E., Van Damme J., Billiau A., Duinkerken N., Lurvink E., Ralph P., Altrock B.W., Kaushansky K., Willemze R., Falkenburg J.H. Human fibroblasts produce granulocyte-CSF, macrophage-CSF and granulocyte-macrophage-CSF following stimulation by interleukin-1 and poly(rI).poly(rC). Blood. 72:1988;860-866.
19. Fried W., Barone J. Residual marrow damage following therapy with cyclophosphamide. Exp. Hematol. 8:1980;610-614.
20. Fried W., Kedo A., Barone J. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma. Cancer Res. 37:1977;1205-1209.
21. Friedenstein A.J., Chailakhyan R.K., Latsinik N.V., Panasyuk A.F., Keiliss-Borok I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Transplantation. 17:1974;331-340.
22. Gaido K., Wierda D. In vitro effects of benzene metabolites on mouse bone marrow stromal cells. Toxicol. Appl. Pharmacol. 76:1984;45-55.
23. Gale, R.P., 1988. Myelosuppressive effects of antineoplastic chemotherapy. In: Testa, N.G., Gale, R.P. (Eds.), Hematopoiesis. Long-term Effects of Chemotherapy. Marcel Dekker, New York, 1988, pp. 63-73.
24. Ganousis L.G., Goon D., Zyglewska T., Wu K.K., Ross D. Cell-specific metabolism in mouse bone marrow stroma: studies of activation and detoxification of benzene metabolites. Mol. Pharmacol. 42:1992;1118-1125.
25. Gibson N.W., Hickman J.A. The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureas. Biochem. Pharmacol. 31:1982;2795-2800.
26. Gibson L.F., Fortney J., Landreth K.S., Piktel D., Ericson S.G., Lynch J.P. Disruption of bone marrow stromal cell function by etoposide. Biol. Blood Marrow Transplant. 3:1997;122-132.
27. Gordon M.Y., Riley G.P., Clarke D. Heparan sulfate is necessary for adhesive interactions between human early hemopoietic progenitor cells and the extracellular matrix of the marrow microenvironment. Leukemia. 2:1988;804-809.
28. Gordon, M.Y., Ford, A.M., Greaves, M.F., 1993. Interactions of hematopoietic progenitor cells with extracellular matrix. In: Long, M.W., Wicha, M.S. (Eds.), The Hematopoietic Microenvironment. Johns Hopkins Univ. Press, Baltimore, 1993, pp. 152-174.
29. Greenberger, J.S., Cohen, G.I., Sakakeeny, M.A., 1984. The development of a system for study of bone marrow transplantation in vitro: effects of X-irradiation dose rate and chemotherapeutic agents on the isolated bone marrow microenvironment. In: Wright, D.G., Greenberger, J.S. (Eds.), Long Term Bone Marrow Culture. Alan R. Liss, New York, 1984, pp. 195-209.
30. Harigaya K., Miller M.E., Cronkite E.P., Drew R.T. The detection of in vivo hematotoxicity of benzene by in vitro liquid bone marrow cultures. Toxicol. Appl. Pharmacol. 60:1981;346-353.
31. Haskell, C.M., 1990. Drugs used in cancer chemotherapy. In: Haskell, C.M. (Ed.), Cancer Treatment. Saunders, Philadelphia, 1990, pp. 44-102.
32. Hauser S.P., Udupa K.B., Lipschitz D.A. Effects of ceftazidime, a beta-lactam antibiotic, on murine haemopoiesis in vitro. Br. J. Haematol. 86:1994;733-739.
33. Hauser S.P., Udupa K.B., Lipschitz D.A. Murine marrow stromal response to myelotoxic agents in vitro. Br. J. Haematol. 95:1996;596-604.
34. Hays E.F., Hale L., Villarreal B., Fitchen J.H. 'Stromal' and hemopoietic stem cell abnormalities in long-term cultures of marrow from busulfan-treated mice. Exp. Hematol. 10:1982;383-392.
35. Hoagland H.C. Hematologic complications of cancer chemotherapy. Semin. Oncol. 9:1992;95-102.
36. Johnston T.P., Montgomery J.A. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems. Cancer Treat. Rep. 70:1986;13-30.
37. Kalechman Y., Sotnik-Barkai I., Albeck M., Sredni B. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O′)tellurate (AS101). Cancer Res. 53:1993;1838-1844.
38. Kincade, P.W., 1994. Cell adhesion mechanisms utilized for lymphohemopoiesis. In: Shimizu, Y. (Ed.), Lymphocyte Adhesion Molecules. R.G. Landes, Austin, 1994, pp. 249-279.
39. Kittler, E.L.W., Quesenberry, P.J., 1993. Stromal cells and clinical implications. In: Long, M.W., Wicha, M.S. (Eds.), The Hematopoietic Microenvironment. Johns Hopkins Univ. Press, Baltimore, 1993, pp. 49-75.
40. Klein G. The extracellular matrix of the hematopoietic microenvironment. Experientia. 51:1995;914-926.
41. Knospe W.H., Blom J., Crosby W.H. Regeneration of locally irradiated bone marrow: II. Induction of regeneration in permanently aplastic medullary cavities. Blood. 31:1968;400-405.
42. Koike R., Miki I., Otoshi M., Totsuka T., Inoue H., Kase H., Saito I., Miyasaka N. Gold sodium thiomalate down-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells. Mol. Pharmacol. 46:1994;599-604.
43. Miller A.C., Schattenberg D.G., Malkinson A.M., Ross D. Decreased content of the IL-1 alpha processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone. Toxicol. Lett. 74:1994;177-184.
44. Morley A., Blake J. An animal model of chronic aplastic marrow failure: I. Late marrow failure after busulfan. Blood. 44:1974;49-56.
45. Mouton J.W., Horrevorts A.M., Mulder P.G.H., Prens E.P., Michel M.F. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers. Antimicrob. Agents Chemother. 34:1990;2307-2311.
46. Nabeshima R., Aizawa S., Nakano M., Toyama K., Sugimoto K., Kaidow A., Imai T., Handa H. Effects of vesnarinone on the bone marrow stromal cell-dependent proliferation and differentiation of HL60 cells in vitro. Exp. Hematol. 25:1997;509-515.
47. Naughton B.A., Sibanda B., Azar L., San Roman J. Differential effects of drugs upon hematopoiesis can be assessed in long-term bone marrow cultures established on nylon screens. Proc. Soc. Exp. Biol. Med. 199:1992;481-490.
48. Neftel K.A., Hauser S.P., Muller M.R. Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. J. Infect. Dis. 152:1985;90-98.
49. Niculescu R., Kalf G.F. A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1alpha on the process. Arch. Toxicol. 69:1995;141-148.
50. Nikkels P.G.J., de Jong J.P., Ploemacher R.E. Long-term effects of cytostatic agents on the hemopoietic stroma: a comparison of four different assays. Leuk. Res. 11:1987;817-825.
51. Papadopoulou L.C., Tsiftsoglou A.S. Effects of hemin on apoptosis, suppression of cytochrome C oxidase gene expression and bone marrow toxicity induced by doxorubicin (adriamycin). Biochem. Pharmacol. 52:1996;713-722.
52. Parrish D.D., Schlosser M.J., Kapeghian J.C., Traina V.M. Activation of CGS 12094 (prinomide metabolite) to 1,4-benzoquinone by myeloperoxidase: implications for human idiosyncratic agranulocytosis. Fundam. Appl. Toxicol. 35:1997;197-204.
53. Pratt, W.B., Ruddon, R.W., Ensminger, W.D., Maybaum, J., 1994. The Anticancer Drugs. Oxford Univ. Press, New York, 1994.
54. Ross D. Metabolic basis of benzene toxicity. Eur. J. Haematol., Suppl. 60:1996;111-118.
55. Ross D.et al. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. Free Radical Res. Commun. 8:1990;373-381.
56. Sakai A. Diclofenac inhibits endothelial cell adhesion molecule expression induced with lipopolysaccharide. Life Sci. 58:1996;2377-2387.
57. Schlosser M.J., Kalf G.F. Metabolic activation of hydroquinone by macrophage peroxidase. Chem. Biol. Interact. 72:1989;191-207.
58. Sharkis S.J., Santos G.W., Colvin M. Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. Blood. 55:1980;521-523.
59. Snyder R., Hedli C.C. An overview of benzene metabolism. Environ. Health Perspect. 104:1996;1165-1171.
60. Subrahmanyam V.V., Ross D., Eastmond D.A., Smith M.T. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radical Biol. Med. 11:1991;495-515.
61. Thomas D.J., Reasor M.J., Wierda D. Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol. Appl. Pharmacol. 97:1989;440-453.
62. Thomas D.J.et al. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol. Pharmacol. 37:1990;255-264.
63. Twerdok L.E., Rembish S.J., Trush M.A. Studies with 1,2-dithiole-3-thione as a chemoprotector of hydroquinone-induced toxicity to DBA/2-derived bone marrow stromal cells. Environ. Health Perspect. 101:1993;172-177.
64. Wathen L.M., DeGowin R.L., Gibson P., Knapp S.A. Residual injury to the hemopoietic microenvironment following sequential radiation and busulfan. Int. J. Radiat. Oncol., Biol., Phys. 8:1982;1315-1322.
65. Williams L.H., Udupa K.B., Lipschitz D.A. Long-term bone marrow culture as a model for host toxicity: the effect of methotrexate on hematopoiesis and adherent layer function. Exp. Hematol. 16:1988;80-87.
66. Xu C.X., Molineux G., Testa N.G., Hendry J.H. Long-term damage to haemopoietic cell subpopulations in mice after repeated treatment with BCNU or cyclophosphamide. Br. J. Cancer. 53:1986;174-176. Suppl. VII.
67. Yang Y.C., Tsai S., Wong G.C., Clark S.C. Interleukin-1 regulation of hematopoietic growth factor production by human stromal fibroblasts. J. Cell. Physiol. 134:1988;292-296.
68. Yoder M.C., Williams D.A. Matrix molecule interactions with hematopoietic stem cells. Exp. Hematol. 23:1995;961-967.